SCHEMBL12545409

SCHEMBL12545409

c1ccc2c(c1)NC1c3ccc(-c4ccc5ccccc5c4)cc3-c3ccccc3N21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 2/20 0.37
▸ HSD17B1 P14061 1/20 0.35
▸ HSD17B2 P37059 1/20 0.35
▸ KDM4E B2RXH2 4/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ NPC1 O15118 3/20 0.34
▸ RAB9A P51151 3/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ POLB P06746 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ GSTP1 P09211 1/20 0.33
▸ ESR1 P03372 1/20 0.33
▸ ESR2 Q92731 1/20 0.33
▸ ALOX5 P09917 1/20 0.33
▸ CYP11B1 P15538 2/20 0.32
▸ CYP11B2 P19099 2/20 0.32
▸ HDAC4 P56524 1/20 0.32
▸ HDAC2 Q92769 1/20 0.32
▸ HDAC8 Q9BY41 1/20 0.32
▸ IDO1 P14902 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12545483 0.88 ALDH1A1 (0.36) KDM4ESMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL21419580 0.84 ALDH1A1 (0.34) AKT1KDM4ESMN1; SMN2ALDH1A1POLB
SCHEMBL22814613 0.81 PDK2 (0.34) IDO1
SCHEMBL18891732 0.81 ALDH1A1 (0.40) KDM4ESMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL12545492 0.80 ALDH1A1 (0.33) KDM4ESMN1; SMN2ALDH1A1MAPTIDO1
SCHEMBL12545571 0.80 ALDH1A1 (0.31) ALDH1A1CYP1A2ALOX15
SCHEMBL14644206 0.80 AKT1 (0.34) AKT1KDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL17014574 0.79 IDO1 (0.43) KDM4ESMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL14781192 0.75 AKT1 (0.32) AKT1PIM1
SCHEMBL18819364 0.75 POLB (0.36) KDM4ESMN1; SMN2NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110127513-A1 NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME LG CHEM, LTD. (KR) 2011-06-02 — — US disclosed
US-20110127513-A1 NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME LG CHEM, LTD. (KR) 2011-06-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110127513-A1 NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME VDAC2, VDAC1, VDAC3 AKT1 3121/4885HSD17B1 3943/4885HSD17B2 3639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback